Details for New Drug Application (NDA): 207234
✉ Email this page to a colleague
The generic ingredient in AZACITIDINE is azacitidine. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the azacitidine profile page.
Summary for 207234
Tradename: | AZACITIDINE |
Applicant: | Natco Pharma Ltd |
Ingredient: | azacitidine |
Patents: | 0 |
Pharmacology for NDA: 207234
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 207234
Suppliers and Packaging for NDA: 207234
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 207234 | ANDA | Dr. Reddy's Laboratories Inc. | 43598-143 | 43598-143-62 | 1 mL in 1 CARTON (43598-143-62) |
AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 207234 | ANDA | Panacea Biotec Limited | 43817-906 | 43817-906-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43817-906-01) / 50 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS, SUBCUTANEOUS | Strength | 100MG/VIAL | ||||
Approval Date: | Jun 23, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription